Dr. Elizabeth Alpert, PhD

Claim this profile
Studies Post-Traumatic Stress Disorder
1 reported clinical trial
3 drugs studied

Clinical Trials Elizabeth Alpert, PhD is currently running

Image of trial facility.

Enhanced PTSD Communication Strategies

for Post-Traumatic Stress Disorder

The purpose of this clinical trial is to learn whether existing treatments for posttraumatic stress disorder (PTSD) can be improved. Two treatments for PTSD, cognitive processing therapy (CPT) and prolonged exposure (PE) will be studied. CPT and PE are effective treatments that are widely available, but interventions are needed to improve patient outcomes in these treatments. The investigators have developed an Adjunctive Writing intervention for Amplifying Response and Engagement (AWARE), which was designed using health communication strategies to enhance CPT and PE by improving communication between patients and therapists about patients' experiences in treatment. This research will investigate whether adding AWARE to CPT and PE will lead to better treatment outcomes compared to CPT and PE provided as usual without AWARE. AWARE includes a brief writing task asking patients about their experiences in treatment, as well as guided therapist responses to improve patient-therapist communication about patients' experiences in treatment. In the first phase of the study (case series phase), CPT or PE with AWARE will be provided to four adults with PTSD to pilot test adding AWARE to CPT and PE, seek patient and provider feedback, and refine AWARE. The first four participants who enroll will be part of the case series and will receive CPT or PE with AWARE. Then, in the second phase of the study, the randomized controlled trial (RCT) phase, the investigators will enroll 50 more adults with PTSD who will be randomly assigned (like flipping a coin) to receive CPT/PE as usual or CPT/PE with AWARE. It is expected that 25 participants will be randomized to CPT/PE with AWARE and 25 participants will be randomized to receive CPT/PE provided as usual. The goals of the RCT phase are to study whether AWARE is acceptable to patients, whether it is feasible to add AWARE to CPT and PE, and whether adding AWARE to CPT and PE improves patient-therapist communication and treatment outcomes compared to CPT/PE as usual.
Recruiting1 award N/A2 criteria

More about Elizabeth Alpert, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Elizabeth Alpert, PhD has experience with
  • Adjunctive Writing To Amplify Response And Engagement (AWARE)
  • Cognitive Processing Therapy (CPT)
  • Prolonged Exposure (PE)
Breakdown of trials Elizabeth Alpert, PhD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elizabeth Alpert, PhD specialize in?
Elizabeth Alpert, PhD focuses on Post-Traumatic Stress Disorder and other conditions. In particular, much of their work with Post-Traumatic Stress Disorder has involved treating patients, or patients who are undergoing treatment.
Is Elizabeth Alpert, PhD currently recruiting for clinical trials?
Yes, Elizabeth Alpert, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Elizabeth Alpert, PhD has studied deeply?
Yes, Elizabeth Alpert, PhD has studied treatments such as Adjunctive writing to amplify response and engagement (AWARE), Cognitive processing therapy (CPT), Prolonged exposure (PE).
What is the best way to schedule an appointment with Elizabeth Alpert, PhD?
Apply for one of the trials that Elizabeth Alpert, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.